InvestorsHub Logo
Followers 19
Posts 837
Boards Moderated 0
Alias Born 01/28/2016

Re: Couch post# 245896

Friday, 03/10/2017 6:05:39 PM

Friday, March 10, 2017 6:05:39 PM

Post# of 402474
Oh shoot. No I'm not saying Phase III are not unimportant and neither is he.

In regards to PPS is what that was referencing. The market (i.e. the patients determine what they get). If they don't like it? It won't be insured but we both agree the logic is there for it to eventually push out even hydrocodone. I argued with him because I'm in genomics and bioinformatics specifically so all I care about is the data (as my natural base intuition). So I emphasized to him the CRL is a problem but we had good Phase III! That's where he jumped in and stated what I really need to be concerned on (to clarify).

"The whole of science is nothing more than a refinement of everyday thinking." -Albert Einstein

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News